NewsBenzingaPiper Sandler maintient sa recommandation « surpondérer » sur Crescent Biopharma et abaisse son objectif de cours à 32 $ Piper Sandler maintient sa recommandation « surpondérer » sur Crescent Biopharma et abaisse son objectif de cours à 32 $ Benzinga 2026.11.13 15:55 (GMT+0) Open on Benzinga Other news Airbnb Co-Founder Joe Gebbia Says He Modernized Federal Retirement System In 6 Months for $1.5 Million After Contractors Spent $100 Million NVIDIA's Jensen Huang Crisis Threatens to Rewrite the Rules of the AI Boom Mondelez's Multi-Million Portfolio Shift: Unloads French Bakery and Cereal Bars Business Ur-Energy Begins Fieldwork For Baseline Studies At Its Lost Solider Project; Will Take Construction Decision For Potential Third Mine After Technical Report Azora Therapeutics Files Prospectus For $250M Mixed Securities Shelf; May Sell Up To $20M Of Stock Under Sales Agreement With Jefferies Chuck Schumer Slams Trump Over Plan to Cut Food Stamps for 6 Million Americans: 'Empty Dinner Plates Across America'
Airbnb Co-Founder Joe Gebbia Says He Modernized Federal Retirement System In 6 Months for $1.5 Million After Contractors Spent $100 Million
Ur-Energy Begins Fieldwork For Baseline Studies At Its Lost Solider Project; Will Take Construction Decision For Potential Third Mine After Technical Report
Azora Therapeutics Files Prospectus For $250M Mixed Securities Shelf; May Sell Up To $20M Of Stock Under Sales Agreement With Jefferies
Chuck Schumer Slams Trump Over Plan to Cut Food Stamps for 6 Million Americans: 'Empty Dinner Plates Across America'